Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “lenalidomide”

4 pharma patents match "lenalidomide" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "lenalidomide" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “lenalidomide” · 30,257 patents in full index Clear search

  1. US 11253591

    Combination of lenalidomide and polypeptide construct, and uses thereof

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  2. US 10342869

    Compositions comprising anti-CD38 antibodies and lenalidomide

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  3. US 10232041

    Combination of lenalidomide and polypeptide construct, and uses thereof

    TEVA PHARMACEUTICALS PTY LTD · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  4. US 9636334

    Combination of lenalidomide and polypeptide construct, and uses thereof

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.